Tag: ai in cancer diagnostics market share

  • Key Trends and Insights into the AI In Cancer Diagnostics Market: Growth Rate and Opportunities to 2034

    Key Trends and Insights into the AI In Cancer Diagnostics Market: Growth Rate and Opportunities to 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the ai in cancer diagnostics market?

    The market for AI in cancer diagnostics has seen significant expansion in the past few years. A rise from $0.66 billion in 2024 to $0.79 billion in 2025 is projected, indicating a compound annual growth rate (CAGR) of 21.0%. The increase during the historic period is a result of various factors such as growing cancer prevalence rates, an influx of data in healthcare, a favorable regulatory climate, emphasis on precision medicine, and the widening of AI application beyond imaging.

    What will be the ai in cancer diagnostics market size in the future?

    The market size of AI in cancer diagnostics is predicted to exhibit swift expansion in the upcoming years, reaching $1.64 billion by 2029, with a CAGR of 19.9%. Factors contributing to the growth in the forecast period encompass emerging explainable AI, escalated global healthcare IT spending, incorporation with electronic health records (EHR), acceptance of personalized medicine, and ongoing enhancements in AI algorithms. Predominant trends within the forecast period involve progress in imaging technologies, technological integration, partnerships among healthcare and technology firms, the surge of digital pathology, and automation in histopathology.

    Get your ai in cancer diagnostics market report here!

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    What main drivers are fueling expansion in the ai in cancer diagnostics market?

    The upward trend in cancer incidences is predicted to boost the expansion of artificial intelligence in the cancer diagnostics market. Cancer, a collection of diseases characterized by irregular cell growth capable of invading or migrating to other body parts, can greatly benefit from the implementation of AI. Incorporating AI into cancer treatment can improve efficiency, precision, and tailored treatment plans, thereby enhancing cancer patients’ prognosis. For example, the National Cancer Institute, a US government agency, projected in May 2024 that about 2 million new cases of cancer would be diagnosed in the U.S in 2024, accompanied by over 611,000 projected deaths. By 2040, new global cancer diagnoses are forecasted to escalate to 29.9 million, with cancer-related fatalities rising to 15.3 million. Consequently, the rising incidence of cancer is fueling the growth of artificial intelligence in the cancer diagnostics market.

    What key areas define the segmentation of the global ai in cancer diagnostics market?

    The AI in cancer diagnostics market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

    3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

    4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations

    Subsegments:

    1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

    2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

    3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

    Who are the dominant players expanding their reach in the ai in cancer diagnostics market?

    Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.ai Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

    How are evolving market trends shaping ai in cancer diagnostics Strategies?

    Key players in the field of AI in cancer diagnostics are witnessing considerable expansion due to advances in AI-enabled digital pathology solutions tailored for cancer detection. The notion of AI-powered digital pathology solutions for diagnosing cancer implies employing AI algorithms to identify cancer and other diagnostic aspects in various tissue types, which leads to a precise and prompt diagnosis of cancer, backing case prioritization, and consistent diagnoses. For example, Dedalus & Ibex Medical Analytics, a Health software firm situated in Europe, unveiled a comprehensive AI-infused digital pathology solution for diagnosing cancer throughout Europe in November 2023. The goal of this solution is to amplify accuracy, offer AI-powered decision-support tools, make reporting more systematic, boost laboratory productivity, and heighten diagnostic certainty.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13567

    Which regions are emerging as leaders in the ai in cancer diagnostics market?

    North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    AI Infrastructure Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-infrastructure-global-market-report

    AI In Oil And Gas Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-oil-and-gas-global-market-report

    AI in Manufacturing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-manufacturing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • In-Depth Insights into the AI In Cancer Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034

    In-Depth Insights into the AI In Cancer Diagnostics Market: Growth, Trends, and Opportunities for 2025-2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Are the Projected Expansion Rates of the AI In Cancer Diagnostics Market for the Next Decade?

    The sphere of AI in cancer diagnostics has seen a surge in market size over the past few years. There is an anticipated growth from $0.66 billion in 2024 to $0.79 billion in 2025, with a compound annual growth rate (CAGR) of 21.0%. The historical growth pattern can be credited to the rise in cancer cases, an overflow of data in the healthcare sector, favourable regulatory climate, an emphasis on precision medicine, and AI applications expanding beyond imaging.

    A swift expansion is predicted for the AI in cancer diagnostics market over the upcoming years, escalating to $1.64 billion in 2029, with a compound annual growth rate (CAGR) of 19.9%. This surge during the forecast duration can be linked to the advent of explainable AI, increased global investment in healthcare IT, integration with electronic health records (EHR), spread of personalized medicine, and ongoing progress in AI algorithms. The period is also expected to witness notable trends such as advancements in imaging technologies, technological fusion, partnerships between healthcare and tech companies, emergence of digital pathology, and automation in histopathology.

    Which Drivers Are Expected to Have the Greatest Impact on the ai in cancer diagnostics Market’s Growth?

    The rising occurrence of cancer is projected to fuel the expansion of artificial intelligence within the field of cancer diagnostics. Cancer includes a variety of illnesses characterized by unusual cell proliferation that might potentially spread to other organs. The incorporation of AI into cancer care seeks to augment efficiency, precision, and custom-made treatment alternatives, ultimately leading to improved results for patients battling cancer. For example, the National Cancer Institute, a government agency in the U.S., revealed in May 2024 that approximately 2 million new cancer diagnoses are expected in the country by 2024, along with over 611,000 projected fatalities. By 2040, global new cancer case estimates are anticipated to elevate to 29.9 million, with deaths due to cancer escalating to 15.3 million. Consequently, the escalating occurrence of cancer is catalyzing the growth of artificial intelligence in the cancer diagnostics market.

    Get Your Free Sample of the Global AI In Cancer Diagnostics Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

    Which Companies Are Redefining the Future of the AI In Cancer Diagnostics Market?

    Major companies operating in the AI in cancer diagnostics market report are:

    • Microsoft Corporation_x000D_

    • IBM Corporation_x000D_

    • Babylon Healthcare Services Ltd._x000D_

    • Verily Life Sciences LLC_x000D_

    • Tempus_x000D_

    What Trends Are Poised to Drive the Future Success of the AI In Cancer Diagnostics Market?

    Significant growth is being observed among major firms in the AI in cancer diagnostics market due to the advancements in AI-empowered digital pathology solutions for cancer diagnosis. These solutions utilize artificial intelligence (AI) algorithms for the detection of cancer and other diagnostic aspects in a variety of tissue types, ensuring precise and prompt cancer diagnosis, aiding in prioritizing cases, and producing consistent diagnoses. For example, Dedalus & Ibex Medical Analytics, a health software company based in Europe, rolled out a comprehensive AI-empowered digital pathology solution for cancer diagnosis throughout Europe in November 2023. The goal of this solution is to bolster accuracy, offer AI-enabled decision support tools, streamline report generation, boost lab efficiency, and heighten diagnostic certainty.

    Get Instant Access to the Global AI In Cancer Diagnostics Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Which Primary Segments of the AI In Cancer Diagnostics Market Are Driving Growth and Industry Transformations?

    The AI in cancer diagnostics market covered in this report is segmented –

    1) By Component: Software Solutions, Hardware, Services

    2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

    3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

    4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations

    Subsegments:

    1) By Software Solutions: Machine Learning Software, Deep Learning Software, Image Analysis Software

    2) By Hardware: AI-Powered Imaging Systems, Diagnostic Devices

    3) By Services: AI Integration Services, Consulting And Training Services, Support And Maintenance Services

    What Are the Leading Regions in the AI In Cancer Diagnostics Market Expansion?

    North America was the largest region in the artificial intelligence in cancer diagnostics market in 2024. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    How Can We Define the AI In Cancer Diagnostics Market and Its Key Components?

    AI in cancer diagnostics refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to analyze medical images, genetic data, or patient histories to assist in the early detection, diagnosis, and prognosis of cancer. These systems can recognize patterns and anomalies in data that might be imperceptible to humans, increasing diagnostic accuracy and efficiency.

    Browse Through More Similar Reports By The Business Research Company:

    AI Infrastructure Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-infrastructure-global-market-report

    AI In Oil And Gas Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-oil-and-gas-global-market-report

    AI in Manufacturing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-manufacturing-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Insights Into The AI In Cancer Diagnostics Market’s Growth Potential 2024-2033

    Insights Into The AI In Cancer Diagnostics Market’s Growth Potential 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the AI In Cancer Diagnostics Market from 2024 to 2033?

    The AI in cancer diagnostics market has expanded rapidly, with growth projected from $0.55 billion in 2023 to $0.66 billion in 2024 at a CAGR of 20.5%. The increase is due to higher cancer incidence rates, healthcare data growth, regulatory support, focus on precision medicine, and expanded AI applications.

    The AI in cancer diagnostics market is projected to reach $1.38 billion by 2028, with a CAGR of 20.3%. The market growth is driven by the emergence of explainable AI, increased healthcare IT spending, the integration of AI with electronic health records (EHR), personalized medicine adoption, and advances in AI algorithms. Major trends include advancements in imaging technologies and collaborations between healthcare and tech companies.

    Claim Your Free Sample of the Global AI In Cancer Diagnostics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13567&type=smp

    What Key Factors Are Fueling the Growth of the AI In Cancer Diagnostics Market?

    The increasing prevalence of cancer is expected to boost the growth of artificial intelligence in cancer diagnostics. AI is enhancing cancer care by improving the efficiency and accuracy of diagnosis, treatment options, and patient outcomes. According to the National Library of Medicine, the global cancer burden is expected to reach 28.4 million cases by 2040, a 47% increase from 2020. This rise in cancer cases is contributing to the growth of AI in cancer diagnostics.

    What Are the Major Segments of the AI In Cancer Diagnostics Market?

    1) By Component: Software Solutions, Hardware, Services

    2) By Cancer Type: Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer And Cervical Cancer, Prostate And Colorectal Cancer, Other Cancer Types

    3) By Application: Screening And Diagnosis, Tumor Identification, Monitoring

    4) By End User: Hospitals, Diagnostic Centers, Medical Research Institutes, Contract Research Organizations

    What New Trends Are Transforming the AI In Cancer Diagnostics Market?

    Companies in the AI in cancer diagnostics market are experiencing growth thanks to advancements in AI-powered digital pathology solutions. These solutions use AI to identify cancer and other diagnostic features in tissue samples, supporting timely and accurate diagnoses. For example, in November 2023, Dedalus & Ibex Medical Analytics, a Europe-based health software company, launched an integrated AI-powered digital pathology solution for cancer diagnosis. This system aims to improve diagnostic accuracy, provide decision support, streamline reporting, and enhance laboratory efficiency across Europe.

    Order Now for Fast Delivery of Your AI In Cancer Diagnostics Market Report!

    https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Which Regions Are Driving Growth in the AI In Cancer Diagnostics Market?

    North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. The regions covered in the ai in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The AI In Cancer Diagnostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ai in cancer diagnostics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The AI In Cancer Diagnostics Market Include

    1. AI In Cancer Diagnostics Market Executive Summary

    2. AI In Cancer Diagnostics Market Segments

    3. AI In Cancer Diagnostics Market Size And Template Market Growth Rate

    4. Key AI In Cancer Diagnostics Market Trends

    5. Major AI In Cancer Diagnostics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

    26. Top AI In Cancer Diagnostics Companies

    27. AI In Cancer Diagnostics Market Opportunities And Strategies

    28. AI In Cancer Diagnostics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    AI In Oil And Gas Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-oil-and-gas-global-market-report

    AI Infrastructure Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-infrastructure-global-market-report

    AI In Genomics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/ai-in-genomics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The AI In Cancer Diagnostics Market

    Comprehensive Analysis On Size, Share, And Drivers Of The AI In Cancer Diagnostics Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

     The AI in cancer diagnostics market has witnessed exponential growth in recent years and is set to continue this trend. This blog delves into the factors driving this surge and the promising future of AI in this critical healthcare sector.

    Recent Market Growth

    Strong Growth from 2023 to 2024

    • Market Size Increase: The market is projected to grow from $0.55 billion in 2023 to $0.66 billion in 2024.
    • CAGR: This represents a compound annual growth rate (CAGR) of 20.5%.

    Key Drivers of Recent Growth

    • Rising Cancer Incidence Rates: Increasing cancer cases have driven the demand for advanced diagnostic tools.
    • Data Explosion in Healthcare: The vast amounts of healthcare data are ideal for AI applications.
    • Supportive Regulatory Environment: Favorable regulations are encouraging the adoption of AI in diagnostics.
    • Focus on Precision Medicine: Precision medicine’s rise emphasizes the need for accurate, AI-driven diagnostics.
    • Expansion of AI Applications: AI’s role is expanding beyond imaging to other diagnostic areas.

    View More On The AI In Cancer Diagnostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report

    Future Market Outlook

    Exponential Growth Forecast

    • Market Size Projection: The market is expected to reach $1.38 billion by 2028.
    • CAGR: The growth rate is projected to be 20.3%.

    Key Drivers of Future Growth

    • Emergence of Explainable AI: More transparent AI models are increasing trust and adoption.
    • Global Increase in Healthcare IT Spending: More investment in healthcare IT is boosting AI integration.
    • Integration with EHRs: Seamless integration with electronic health records is enhancing diagnostic capabilities.
    • Personalized Medicine Adoption: Personalized treatment plans rely heavily on accurate diagnostics.
    • Advances in AI Algorithms: Ongoing improvements in AI algorithms are enhancing diagnostic accuracy.

    Trends Shaping the Market

    Advancements in Imaging Technologies

    • Enhanced Imaging: New imaging technologies are improving the accuracy of cancer detection.
    • Technological Convergence: The convergence of different technologies is leading to more sophisticated diagnostic tools.

    Collaborations and Digital Pathology

    • Healthcare and Tech Collaborations: Partnerships between healthcare providers and tech companies are driving innovation.
    • Rise of Digital Pathology: Digital pathology is transforming the way cancer is diagnosed.

    Automation in Histopathology

    • Streamlined Processes: Automation in histopathology is improving efficiency and accuracy in diagnostics.

    Rising Cancer Cases Propel Advances

    Increasing Prevalence of Cancer

    • Global Cancer Burden: The global cancer burden is expected to reach 28.4 million cases by 2040, a 47% rise from 2020.
    • AI’s Role: AI is crucial in enhancing efficiency, accuracy, and personalized treatment in cancer care.

    Major Companies in the Market

    Leading Players

    • Microsoft Corporation
    • IBM Corporation
    • Babylon Healthcare Services Ltd.
    • Verily Life Sciences LLC
    • Paige AI Inc.
    • Ada Health GmbH
    • Viz.ai Inc.
    • Butterfly Network Inc.
    • Insilico Medicine
    • BenevolentAI SA SA
    • Enlitic Inc.
    • Ibex Medical Analytics
    • Kheiron Medical Technologies Limited
    • CureMetrix Inc.
    • CancerIQ Inc.

    AI-Driven Pathology Solutions Transforming Cancer Diagnosis

    Digital Pathology Solutions

    • AI Algorithms: AI algorithms are being used to detect cancer in various tissue types.
    • Improved Diagnostic Accuracy: These solutions provide accurate, timely diagnoses and enhance laboratory efficiency.

    Case Study: Dedalus & Ibex Medical Analytics

    • New Solution: In November 2023, Dedalus and Ibex Medical Analytics launched an AI-powered digital pathology solution in Europe.
    • Impact: This solution aims to improve diagnostic accuracy, streamline reporting, and enhance laboratory efficiency.

    Strategic Acquisitions in the Market

    Lunit Acquires Volpara

    • Acquisition Details: In December 2023, Lunit acquired Volpara for $193 million.
    • Strategic Benefits: This acquisition strengthens Lunit’s position in AI-driven cancer diagnostics, especially in the U.S. market.

    Market Segmentation

    By Component

    • Software Solutions
    • Hardware
    • Services

    By Cancer Type

    • Breast Cancer
    • Lung Cancer
    • Brain Tumor
    • Skin Cancer and Cervical Cancer
    • Prostate and Colorectal Cancer
    • Other Cancer Types

    By Application

    • Screening and Diagnosis
    • Tumor Identification
    • Monitoring

    By End User

    • Hospitals
    • Diagnostic Centers
    • Medical Research Institutes
    • Contract Research Organizations

    Regional Insights

    • North America: In 2023, North America was the largest region in the AI in cancer diagnostics market.

    Conclusion

    The AI in cancer diagnostics market is on a rapid growth trajectory, driven by technological advancements, rising cancer cases, and increasing healthcare investments. With continued innovation and strategic collaborations, AI is set to revolutionize cancer diagnostics, offering hope for improved patient outcomes and more personalized treatment approaches.

    Request A Sample Of The Global AI In Cancer Diagnostics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13567&type=smp